Acasă › Anemie aplastică › Maryland
Studii clinice pentru Anemie aplastică în Maryland
10 studii pentru Anemie aplastică caută participanți în Maryland.
Orașe în Maryland
Text oficial al studiului (în engleză)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- National Institutes of Health Clinical Center, Bethesda
În curs de recrutareFaza 1/2
Vârste de la 12 la 120 · Toate sexele · Actualizat 2 oct. 2026 · NCT06303193Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- National Institutes of Health Clinical Center, Bethesda
În curs de recrutareFaza 1/2
Vârste de la 4 la 75 · Toate sexele · Actualizat 1 oct. 2026 · NCT03173937Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
În curs de recrutareStudiu observațional
Vârste de la 2 la 99 · Toate sexele · Actualizat 30 sept. 2026 · NCT05012111Cancer in Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
- National Cancer Institute - Shady Grove, Rockville
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
1 Day – 100 Years · Toate sexele · Actualizat 30 sept. 2026 · NCT00027274Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
În curs de recrutareFaza 1 timpurie
Vârste de 18 ani și peste · Toate sexele · Actualizat 24 sept. 2026 · NCT06398457Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- National Institutes of Health Clinical Center, Bethesda
În curs de recrutareFaza 2
Vârste de la 4 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT01174108Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
- National Institutes of Health Clinical Center, Bethesda
În curs de recrutareFaza 2
Vârste de la 4 la 75 · Toate sexele · Actualizat 8 sept. 2026 · NCT03520647A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 6 iul. 2026 · NCT01351545Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- National Institutes of Health Clinical Center, Bethesda
În curs de recrutareFaza 2
Vârste de la 3 la 99 · Toate sexele · Actualizat 9 mar. 2026 · NCT04304820Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
- Johns Hopkins University, Baltimore
În curs de recrutareFaza 2
Vârste de la 3 la 75 · Toate sexele · Actualizat 17 feb. 2026 · NCT06517641Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.